Literature DB >> 26465636

In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.

Md Tozammel Hoque1, Arpit Shah1, Vijay More2, David S Miller2, Reina Bendayan1.   

Abstract

Breast cancer resistance protein (Bcrp/Abcg2) localized at the blood-brain barrier (BBB) limits permeability into the brain of many xenobiotics, including pharmacological agents. Peroxisome proliferator-activated receptor α (Pparα), a ligand-activated transcription factor, primarily involved in lipid metabolism, has been shown to regulate the functional expression of Bcrp in human cerebral microvascular endothelial cells (hCMEC/D3). The aim of this study was to investigate ex vivo and in vivo, the regulation of Bcrp by Pparα in an intact BBB. Ex vivo quantitative real-time PCR and immunoblot analyses showed significant up-regulation of Abcg2/Bcrp mRNA and protein levels in CD-1 mouse brain capillaries incubated with clofibrate, a Pparα ligand. Fluorescence-based transport assays in CD-1 and C57BL/6 brain capillaries showed that exposure to clofibrate significantly increased Bcrp transport activity. This increase was not observed in capillaries isolated from Pparα knockout mice. In vivo, we found: i) significant Bcrp protein up-regulation in clofibrate-dosed CD-1 and C57BL/6 capillary lysates, but no effect in Pparα knockout capillary lysates, and ii) significantly increased Bcrp transport activity in capillaries isolated from clofibrate-treated mice. These results demonstrate an increase in Bcrp functional expression by Pparα in brain capillaries, and suggest that Pparα is another nuclear receptor that can contribute to the regulation of membrane efflux transporters and drug permeability at the BBB. We propose the involvement of the following pathways in clofibrate-mediated induction of the drug transporter Abcg2/Bcrp mRNA, protein expression and function by the nuclear receptor Pparα, in mouse brain capillary endothelial cells. Upon activation with clofibrate (Pparα, ligand), Pparα complex translocates from the cytoplasm into the nucleus and further recruits coactivators and transcription machinery which induce the transcription of Abcg2 gene and ultimately results in upregulation of Bcrp protein expression and function. These findings have significant implications since Bcrp is known to play an important role at the BBB in preventing the permeability of several xenobiotics and drugs into the brain.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  Blood-brain barrier; brain capillaries; breast cancer resistant protein; nuclear receptors; peroxisome proliferator-activated receptor alpha; regulation of drug transport

Mesh:

Substances:

Year:  2015        PMID: 26465636      PMCID: PMC4729455          DOI: 10.1111/jnc.13389

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  46 in total

1.  Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells.

Authors:  Gary N Y Chan; Md Tozammel Hoque; Carolyn L Cummins; Reina Bendayan
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

Review 2.  Functional expression and localization of P-glycoprotein at the blood brain barrier.

Authors:  Reina Bendayan; Gloria Lee; Moise Bendayan
Journal:  Microsc Res Tech       Date:  2002-06-01       Impact factor: 2.769

Review 3.  Biopharmaceutical drug targeting to the brain.

Authors:  William M Pardridge
Journal:  J Drug Target       Date:  2010-04       Impact factor: 5.121

4.  In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation.

Authors:  Björn Bauer; Xiaodong Yang; Anika M S Hartz; Emily R Olson; Rong Zhao; J Cory Kalvass; Gary M Pollack; David S Miller
Journal:  Mol Pharmacol       Date:  2006-07-12       Impact factor: 4.436

5.  Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Kah Poh Tan; Bernice Wang; Mingdong Yang; Paul C Boutros; Jane Macaulay; Haibo Xu; Andrew I Chuang; Kazuhiro Kosuge; Mika Yamamoto; Shinichiro Takahashi; Alex M L Wu; Douglas D Ross; Patricia A Harper; Shinya Ito
Journal:  Mol Pharmacol       Date:  2010-05-11       Impact factor: 4.436

6.  Characterization of palmitoylation of ATP binding cassette transporter G1: effect on protein trafficking and function.

Authors:  Hong-mei Gu; Ge Li; Xia Gao; Luc G Berthiaume; Da-wei Zhang
Journal:  Biochim Biophys Acta       Date:  2013-02-04

7.  Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.

Authors:  Christian Schachtrup; Tanja Emmler; Bertram Bleck; Anton Sandqvist; Friedrich Spener
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

8.  P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.

Authors:  Nienke A de Vries; Jin Zhao; Emily Kroon; Tessa Buckle; Jos H Beijnen; Olaf van Tellingen
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

9.  The role of human ABC transporter ABCG2 (BCRP) in pharmacotherapy.

Authors:  Toshihisa Ishikawa
Journal:  Adv Drug Deliv Rev       Date:  2008-12-31       Impact factor: 15.470

10.  PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells.

Authors:  Wen Huang; Geun Bae Rha; Min-Joon Han; Sung Yong Eum; Ibolya E András; Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  J Neurochem       Date:  2008-08-14       Impact factor: 5.372

View more
  11 in total

Review 1.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

2.  Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.

Authors:  Gary N Y Chan; Rebecca A Evans; David B Banks; Emily V Mesev; David S Miller; Ronald E Cannon
Journal:  Neurosci Lett       Date:  2016-12-21       Impact factor: 3.046

3.  Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.

Authors:  Lissa N Francois; Ludwik Gorczyca; Jianyao Du; Kristin M Bircsak; Elizabeth Yen; Xia Wen; Mei-Juan Tu; Ai-Ming Yu; Nicholas P Illsley; Stacy Zamudio; Lauren M Aleksunes
Journal:  Placenta       Date:  2017-01-24       Impact factor: 3.481

4.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

6.  Regulation of Reduced Folate Carrier (RFC) by Vitamin D Receptor at the Blood-Brain Barrier.

Authors:  Camille Alam; Md Tozammel Hoque; Richard H Finnell; I David Goldman; Reina Bendayan
Journal:  Mol Pharm       Date:  2017-09-26       Impact factor: 4.939

7.  Developmental differences in the expression of ABC transporters at rat brain barrier interfaces following chronic exposure to diallyl sulfide.

Authors:  Liam M Koehn; Katarzyna M Dziegielewska; Kjeld Møllgård; Elodie Saudrais; Nathalie Strazielle; Jean-Francois Ghersi-Egea; Norman R Saunders; Mark D Habgood
Journal:  Sci Rep       Date:  2019-04-12       Impact factor: 4.379

Review 8.  Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity.

Authors:  Junzhi Yang; Bianca G Reilly; Thomas P Davis; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2018-10-18       Impact factor: 6.321

9.  Determinants of drug entry into the developing brain.

Authors:  Liam Koehn; Mark Habgood; Yifan Huang; Katarzyna Dziegielewska; Norman Saunders
Journal:  F1000Res       Date:  2019-08-07

Review 10.  ABC efflux transporters at blood-central nervous system barriers and their implications for treating spinal cord disorders.

Authors:  Liam M Koehn
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.